Indeed, MSC transplantation into HD patients can serve as an alternative strategy to increase exogenous and endogenous BDNF expression [45–47], as has been shown, for instance, in subpopulations of human MSCs [50]. The gene discussed is BDNF; the disease is Huntington disease.